Immediate 11-Site Technegas Rollout at University Hospitals
Filed with ASX · · 2 pages · English
Summary by 6ix AI
This system-wide rollout is set to occur within a few weeks, showcasing Cyclopharm's commitment to expanding its presence in the US healthcare market. The agreement is expected to generate recurring revenue through functional ventilation imaging procedures as Technegas is adopted across the UH network. Cyclopharm's Managing Director emphasized the importance of this agreement in reinforcing the company's growth strategy in the US.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Cyclopharm
- CYC First-Half 2026 Update
- USA Technegas Expansion Update
- CYC Secures Multi-Site Agreement with Northwestern Medicine
- CYC Signs Enterprise Agreement with UPHS
- Preliminary Final Report
Later from Cyclopharm
- ausbiz TV Presentation
- New US Lung Imaging Guidelines Name Technegas as Preferred A
- Half Yearly Report and Accounts
- CYC 1H2026 Results Summary
- Cyclopharm 1H 2026 Results Webinar
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm